Glashuetten, Germany

Eugen Uhlmann

USPTO Granted Patents = 80 

 

 

Average Co-Inventor Count = 3.4

ph-index = 21

Forward Citations = 1,324(Granted Patents)

Forward Citations (Not Self Cited) = 1,227(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Konigstein, DE (1987)
  • Belmont, MA (US) (1989)
  • Konigstein/Taunus, DE (1995)
  • Glashuten, DE (1999)
  • Glashutten/Taunus, DE (1991 - 2000)
  • Glashütten/Taunus, DE (2001 - 2005)
  • Glashuetter, DE (2010)
  • Glashuetten, DE (2000 - 2019)
  • Glashutten, DE (1994 - 2020)
  • Glashütten, DE (2001 - 2020)

Company Filing History:

goldMedal30 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents
silverMedal11 out of 27 
 
Coley Pharmaceutical Gmbh
 patents
bronzeMedal11 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
48 out of 41 
 
Coley Pharmaceutical Group, Inc.
 patents
57 out of 1,829 
 
Sanofi-a Ventis Deutschland Gmbh
 patents
66 out of 153 
 
Translate Bio, Inc.
 patents
75 out of 6 
 
Isarna Therapeutics Gmbh
 patents
83 out of 3 
 
Adiutide Pharmaceuticals Gmbh
 patents
92 out of 2,893 
 
The General Hospital Corporation
 patents
102 out of 4,455 
 
Pfizer Corporation
 patents
111 out of 4 
 
Hoescht Aktiengesellschaft
 patents
121 out of 4 
 
Rana Therapeutics, Inc.
 patents
131 out of 1 
 
501 Hoechst Aktiengesellschaft
 patent
141 out of 9 
 
Hoechst Gmbh
 patents
151 out of 1 
 
Adiuttide Pharmaceuticals Gmbh
 patent
161 out of 377 
 
Aventis Pharma S.a.
 patents
171 out of 1,743 
 
Institut National De La Sante Et De La Recherche Medicale
 patents
181 out of 5,081 
 
Centre National De La Recherche Scientifique
 patents
191 out of 832,843 
Other
 patents
where one patent can have more than one assignee

Years Active: 1987-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Oligonucleotide Compounds
Immunostimulatory Activity
TGF-beta Oligonucleotides
CpG Oligonucleotide Analogs
Gene Expression Inhibition
Polyamide Nucleic Acids
Antisense Oligonucleotides
Nucleic Acid Conjugates
Modified Sugar Moieties
Hydrophobic T Analogs
Oligoribonucleotide Derivatives
Cleavable Linkers
80 patents (USPTO):Explore Patents

Title: The Innovative Journey of Eugen Uhlmann

Introduction:

Eugen Uhlmann, a pioneering inventor hailing from Glashuetten, Germany, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Eugen Uhlmann's latest patents include advancements in renewable energy technologies, smart home devices, and sustainable transportation solutions, showcasing his commitment to creating a more sustainable future.

Career Highlights:

Throughout his illustrious career, Eugen Uhlmann has been recognized for his innovative spirit and dedication to pushing the boundaries of technological advancement. His work has revolutionized industries such as telecommunications, robotics, and healthcare.

Collaborations:

Eugen Uhlmann has collaborated with leading research institutions, universities, and multinational corporations to bring his inventions to life. His ability to work across disciplines and industries has led to the development of cutting-edge technologies with far-reaching impacts.

Conclusion:

In conclusion, Eugen Uhlmann's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to push the limits of what is possible in the realm of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…